Hc Biopharma Inc.
Clinical trials sponsored by Hc Biopharma Inc., explained in plain language.
-
New hope for lung cancer: experimental drug HC010 enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called HC010 in 50 people with advanced non-small cell lung cancer that has a specific marker (PD-L1 positive). The goal is to see if the drug can shrink tumors and to check for side effects. Participants receive the drug by injection, and th…
Phase: PHASE2 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 26, 2026 07:05 UTC
-
New drug combo aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called HC010 combined with chemotherapy in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and check for side effects. About 331 participants will take part, and resea…
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New drug combo hopes to shrink lung tumors
Disease control Recruiting nowThis early-stage study tests a new drug called HC010 combined with chemotherapy in people with advanced lung cancer. The main goal is to find a safe dose and see if the combination helps control the disease. About 328 participants will take part.
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC